Chile -
español -
ISPC (Instituto de Salud Pública de Chile)
redken coloracion permanente acondicionadora color gels colors 5 ng chanel y gmg st tropez
l'oreal chile s.a. - sin formulas
Unión Europea -
español -
EMA (European Medicines Agency)
ultomiris
alexion europe sas - ravulizumab - hemoglobinuria, paroxística - inmunosupresores selectivos - paroxysmal nocturnal haemoglobinuria (pnh)ultomiris is indicated in the treatment of adult and paediatric patients with a body weight of 10 kg or above with pnh:- in patients with haemolysis with clinical symptom(s) indicative of high disease activity. - in patients who are clinically stable after having been treated with eculizumab for at least the past 6 months (see section 5. atypical haemolytic uremic syndrome (ahus)ultomiris is indicated in the treatment of patients with a body weight of 10 kg or above with ahus who are complement inhibitor treatment-naïve or have received eculizumab for at least 3 months and have evidence of response to eculizumab (see section 5. generalized myasthenia gravis (gmg)ultomiris is indicated as an add-on to standard therapy for the treatment of adult patients with gmg who are anti-acetylcholine receptor (achr) antibody-positive. neuromyelitis optica spectrum disorder (nmosd)ultomiris is indicated in the treatment of adult patients with nmosd who are anti-aquaporin 4 (aqp4) antibody-positive (see section 5. ultomiris is indicated in the treatment of adult patients with paroxysmal nocturnal haemoglobinuria (pnh):- in patients with haemolysis with clinical symptom(s) indicative of high disease activity. - in patients who are clinically stable after having been treated with eculizumab for at least the past 6 months. ultomiris is indicated in the treatment of adult patients with atypical haemolytic uremic syndrome (ahus) who are complement inhibitor treatment-naïve or have received eculizumab for at least 3 months and have evidence of response to eculizumab.
Unión Europea -
español -
EMA (European Medicines Agency)
duloxetine boehringer ingelheim
boehringer ingelheim international gmbh - duloxetina - neuropatías diabéticas - psychoanaleptics, - tratamiento del dolor neuropático periférico diabético en adultos.
España -
español -
AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)
drosure diario 0,03 mg/3 mg comprimidos recubiertos con pelicula efg
laboratorios effik, sociedade unipessoal lda - drospirenona, etinilestradiol - excipientes: lactosa monohidrato,almidon de maiz,almidon pregelatinizado,polisorbato 80,lactosa anhidra - anticonceptivos hormonales para uso sistÉmico - progestágenos y estrógenos, preparados de dosis fijas - drospirenona y estrógeno
España -
español -
AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)
yasmin 3 mg/0,03 mg comprimidos recubiertos con pelicula
bayer hellas abee - drospirenona, etinilestradiol - excipientes: almidon de maiz,lactosa monohidrato,almidon de maiz pregelatinizado - anticonceptivos hormonales para uso sistÉmico - progestágenos y estrógenos, preparados de dosis fijas - drospirenona y estrógeno
Perú -
español -
DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)
recormon 30000 ui/0.6 ml solucion inyectable
roche farma (peru) s.a. - droguerÍa - ep oetina beta - solucion inyectable - 30000ui/0.6ml - por jeringa precargada 6.00 ml - - eritropoyetina
España -
español -
AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)
bremon unidía 500 mg comprimidos de liberación modificada
esteve pharmaceuticals s.a. - claritromicina - comprimido de liberaciÓn modificada - 500 mg - claritromicina 500 mg - claritromicina
España -
español -
AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)
ebastina aristo 10 mg comprimidos recubiertos con pelicula efg
aristo pharma iberia s.l. - ebastina - comprimido recubierto con pelÍcula - 10 mg - ebastina 10 mg - ebastina
España -
español -
AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)
m+pac emulsión inyectable
merck sharp & dohme animal health s.l. - mycoplasma hyopneumoniae (cepa attc nº 25934) - emulsiÓn inyectable - mycoplasma hyopneumoniae (cepa attc nº 25934) minimo 1,47 - mycoplasma - cerdos de engorde
España -
español -
AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)
montelukast genthon 10 mg comprimidos recubiertos con pelicula efg
genthon bv - montelukast sodico - excipientes: croscarmelosa sodica,lactosa monohidrato - otros agentes contra padecimientos obstructivos de las - antagonistas del receptor de leucotrienos - montelukast